Rapid Sequence Intubation

← Back to Index (🚑 Emergencies and Critical Care)

Definition and Core Principles

Indications for Rapid Sequence Intubation

Contraindications

Precautions and Clinical Nuances

The Seven P's of Rapid Sequence Intubation

Preparation

Preoxygenation

Pretreatment

Paralysis and Induction

Positioning and Protection

Placement and Proof

Post-Intubation Management

Pharmacological Agents for RSI

Drug Class Agent Clinical Profile and Key Nuances
Induction Ketamine Dissociative anesthetic with profound analgesia and fast onset. Causes bronchodilation, making it the agent of choice for severe asthma. Increases heart rate and blood pressure.
Induction Etomidate Fast onset with minimal cardiovascular depressant effects. Lacks analgesic properties. Carries a risk of adrenal suppression.
Induction Propofol Fast-acting hypnotic that reduces ICP and possesses antiemetic properties. Causes potent, dose-dependent vasodilation and hypotension.
Induction Midazolam Benzodiazepine with profound amnestic properties. Has a relatively longer onset of action compared to ketamine or etomidate and can cause venodilation.
Paralytic Succinylcholine Depolarizing NMBA with an extremely rapid onset (40-60 seconds) and short duration (6-10 minutes). Can cause hyperkalemia and increased ICP.
Paralytic Rocuronium Non-depolarizing NMBA with an intermediate onset (60-90 seconds) and prolonged duration (45 minutes). The agent of choice if succinylcholine is contraindicated or if sugammadex is available for rapid reversal.